{
    "code": "02022149",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022149",
    "time": "2020-02-25 12:51:15",
    "許可證字號": "衛署藥輸字第022149號",
    "註銷狀態": "已註銷",
    "註銷日期": "102\/12\/16",
    "註銷理由": "未展延而逾期者",
    "有效日期": "99\/01\/16",
    "發證日期": "87\/04\/30",
    "許可證種類": "製　劑",
    "舊證字號": "02016264",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202214900",
    "中文品名": "恩特來持續性膠囊錠８０公絲",
    "英文品名": "INDERAL LA-80 CAPSULES",
    "適應症": "狹心症、不整律（上心室不整律、心室性心搏過速）原發性及腎性高血壓、偏頭痛、控制原發性震顫、控制焦慮性心搏過速、甲狀腺毒症的輔助劑、親鉻細胞瘤",
    "劑型": "133持續性藥效膠囊劑",
    "包裝": "14-1000粒盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
        "申請商地址": "台北市大安區敦化南路二段207號21樓",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2404400310",
            "成分名稱": "PROPRANOLOL HCL",
            "含量描述": "(PH EUR) 80",
            "含量": "",
            "單位": "MG"
        }
    ]
}